Format

Send to

Choose Destination
Am J Hypertens. 2016 Jan;29(1):17-24. doi: 10.1093/ajh/hpv069. Epub 2015 May 23.

Genetic Risk Score for Essential Hypertension and Risk of Preeclampsia.

Author information

1
Department of Epidemiology, College of Public Health, University of Iowa, Iowa City, Iowa, USA;
2
Department of Epidemiology, College of Public Health, University of Iowa, Iowa City, Iowa, USA; Department of Genetics, University of North Carolina-Chapel Hill, Chapel Hill, North Carolina, USA;
3
Department of Epidemiology, School of Public Health, Brown University, Providence, Rhode Island, USA;
4
Center for Human Genetic Research and Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA; Program in Medical and Population Genetics, Broad Institute, Cambridge, Massachusetts, USA;
5
Department of Surgery, Penn Transplant Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Center for Applied Genomics, Abramson Research Center, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA;
6
Department of Biostatistics, University of Iowa College of Public Health, Iowa City, Iowa, USA;
7
Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut, USA;
8
Department of Environmental Health Sciences, Yale School of Public Health, New Haven, Connecticut, USA.
9
Department of Epidemiology, College of Public Health, University of Iowa, Iowa City, Iowa, USA; kelli-ryckman@uiowa.edu.

Abstract

BACKGROUND:

Preeclampsia is a hypertensive complication of pregnancy characterized by novel onset of hypertension after 20 weeks gestation, accompanied by proteinuria. Epidemiological evidence suggests that genetic susceptibility exists for preeclampsia; however, whether preeclampsia is the result of underlying genetic risk for essential hypertension has yet to be investigated. Based on the hypertensive state that is characteristic of preeclampsia, we aimed to determine if established genetic risk scores (GRSs) for hypertension and blood pressure are associated with preeclampsia.

METHODS:

Subjects consisted of 162 preeclamptic cases and 108 normotensive pregnant controls, all of Iowa residence. Subjects' DNA was extracted from buccal swab samples and genotyped on the Affymetrix Genome-wide Human SNP Array 6.0 (Affymetrix, Santa Clara, CA). Missing genotypes were imputed using MaCH and Minimac software. GRSs were calculated for hypertension, systolic blood pressure (SBP), diastolic blood pressure (DBP), and mean arterial pressure (MAP) using established genetic risk loci for each outcome. Regression analyses were performed to determine the association between GRS and risk of preeclampsia. These analyses were replicated in an independent US population of 516 cases and 1,097 controls of European ancestry.

RESULTS:

GRSs for hypertension, SBP, DBP, and MAP were not significantly associated with risk for preeclampsia (P > 0.189). The results of the replication analysis also yielded nonsignificant associations.

CONCLUSIONS:

GRSs for hypertension and blood pressure are not associated with preeclampsia, suggesting that an underlying predisposition to essential hypertension is not on the causal pathway of preeclampsia.

KEYWORDS:

blood pressure; genetic epidemiology; genetic predisposition to disease; hypertension; maternal; preeclampsia; pregnancy.

PMID:
26002928
PMCID:
PMC4692983
DOI:
10.1093/ajh/hpv069
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Silverchair Information Systems Icon for PubMed Central
Loading ...
Support Center